Inspire Medical Systems, Inc. Increase (Decrease) in Accrued Liabilities
Inspire Medical Systems, Inc. (INSP) reported Increase (Decrease) in Accrued Liabilities of -$791.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2024-11-04
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-09-30 was $7.89M, a 83.26% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-06-30 was $3.72M, a 19.10% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for the quarter ending 2024-03-31 was -$12.40M.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for the quarter ending 2023-09-30 was $4.31M, a 54.39% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for fiscal 2018 was $3.58M, a 166.84% increase from fiscal 2017.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for fiscal 2017 was $1.34M, a 71.39% increase from fiscal 2016.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was $783.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $11.61M derived: sum of 2 quarters · filed 2024-11-04 | -$791.00K 10-Q · filed 2024-11-04 | ||||
| 2024-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$8.68M 10-Q · filed 2024-08-06 | |||||
| 2024-03-31 | -$12.40M 10-Q · filed 2024-05-07 | ||||||
| 2023-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $7.43M derived: sum of 2 quarters · filed 2024-11-04 | -$3.19M 10-Q · filed 2024-11-04 | ||||
| 2023-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$7.50M 10-Q · filed 2024-08-06 | |||||
| 2023-03-31 | -$10.62M 10-Q · filed 2024-05-07 | ||||||
| 2022-09-30 | $9.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $13.95M derived: sum of 2 quarters · filed 2023-11-07 | $7.03M 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$2.41M 10-Q · filed 2023-08-01 | |||||
| 2022-03-31 | -$6.92M 10-Q · filed 2023-05-02 | ||||||
| 2021-09-30 | $4.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $7.28M derived: sum of 2 quarters · filed 2022-11-01 | $4.23M 10-Q · filed 2022-11-01 | ||||
| 2021-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$717.00K 10-Q · filed 2022-08-02 | |||||
| 2021-03-31 | -$3.05M 10-Q · filed 2022-05-03 | ||||||
| 2020-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $3.56M derived: sum of 2 quarters · filed 2021-11-02 | -$931.00K 10-Q · filed 2021-11-02 | ||||
| 2020-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$4.46M 10-Q · filed 2021-08-03 | |||||
| 2020-03-31 | -$4.49M 10-Q · filed 2021-05-04 | ||||||
| 2019-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $2.79M derived: sum of 2 quarters · filed 2020-11-02 | -$467.00K 10-Q · filed 2020-11-02 | $156.00K 10-Q · filed 2019-11-05 | $2.12M derived: sum of 4 quarters · filed 2020-11-02 | ||
| 2019-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$2.13M 10-Q · filed 2020-08-04 | -$1.75M 10-Q · filed 2019-08-06 | $449.00K derived: sum of 3 quarters · filed 2020-08-04 | $1.22M derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2019-03-31 | -$3.26M 10-Q · filed 2020-05-05 | -$3.10M 10-Q · filed 2019-05-07 | -$674.00K derived: sum of 2 quarters · filed 2020-05-05 | $96.00K derived: sum of 3 quarters · filed 2020-05-05 | $1.15M derived: sum of 4 quarters · filed 2020-05-05 | ||
| 2018-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.35M derived: sum of 2 quarters · filed 2019-11-05 | $4.41M derived: sum of 3 quarters · filed 2019-11-05 | $3.58M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $770.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.82M derived: sum of 2 quarters · filed 2019-11-05 | $997.00K 10-Q · filed 2019-11-05 | $1.75M derived: sum of 4 quarters · filed 2019-11-05 | |||
| 2018-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $227.00K 10-Q · filed 2019-08-06 | $976.00K derived: sum of 3 quarters · filed 2019-08-06 | $2.10M derived: sum of 4 quarters · filed 2019-08-06 | |||
| 2018-03-31 | -$825.00K 10-Q · filed 2019-05-07 | -$76.00K derived: sum of 2 quarters · filed 2019-05-07 | $1.05M derived: sum of 3 quarters · filed 2019-05-07 | $1.61M derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $749.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.87M derived: sum of 2 quarters · filed 2019-02-26 | $2.43M derived: sum of 3 quarters · filed 2019-02-26 | $1.34M 10-K · filed 2019-02-26 | |||
| 2017-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.68M derived: sum of 2 quarters · filed 2018-11-06 | $593.00K 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $559.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$532.00K 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | -$1.09M 10-Q · filed 2018-06-07 | ||||||
| 2016-12-31 | $783.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |